• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类VI型成骨不全症骨骼独特的微米和纳米级矿化模式。

Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.

作者信息

Fratzl-Zelman Nadja, Schmidt Ingo, Roschger Paul, Roschger Andreas, Glorieux Francis H, Klaushofer Klaus, Wagermaier Wolfgang, Rauch Frank, Fratzl Peter

机构信息

Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of WGKK and AUVA Trauma Center Meidling, 1st Med. Dept. Hanusch Hospital, 1140 Vienna, Austria.

Max Planck Institute of Colloids and Interfaces, Dept. of Biomaterials, 14424 Potsdam, Germany.

出版信息

Bone. 2015 Apr;73:233-41. doi: 10.1016/j.bone.2014.12.023. Epub 2014 Dec 29.

DOI:10.1016/j.bone.2014.12.023
PMID:25554599
Abstract

Osteogenesis imperfecta (OI) is a heterogeneous group of inheritable connective tissue disorders characterized by mutation in genes involved in collagen synthesis and leading to increased bone fragility, low bone mass, impaired bone material properties and abnormally high bone matrix mineralization. Recessive OI type VI is caused by mutation in SERPINF1 leading to a loss-of-function of pigment epithelium-derived factor (PEDF) a collagen-binding protein with potent antiangiogenic activity. Affected patients develop a severe OI phenotype with a striking histological characteristic, rare in other OI types, of an excess of osteoid tissue and prolonged mineralization lag time. To get insights into matrix mineralization, we evaluated biopsies from 9 affected children by quantitative and by high-resolution backscattered electron imaging and assessed bone mineralization density distribution. Thickness, shape and arrangement of mineral particles were measured in a subset of 4 patients by synchrotron small angle X-ray scattering. Typical calcium content in the bone matrix was found to be increased compared to controls, even exceeding values found previously in OI patients with collagen-gene mutations. A main characteristic however, is the coexistence of this highly mineralized bone matrix with seams showing abnormally low mineral content. Atypical collagen fibril organization was found in the perilacunar region of young osteocytes, suggesting a disturbance in the early steps of mineralization. These observations are consistent with the presence of a heterogeneous population of mineral particles with unusual size, shape and arrangement, especially in the region with lower mineral content. The majority of the particles in the highly mineralized bone areas were less disorganized, but smaller and more densely packed than in controls and in previously measured OI patients. These data suggest that the lack of PEDF impairs a proper osteoblast-osteocyte transition and consequently affects the early steps of mineralization, downstream collagen assembly making OI type VI different from "classical" OI with mutations in collagen-type I encoding genes, despite the typical hypermineralization of the bone matrix.

摘要

成骨不全症(OI)是一组遗传性结缔组织疾病,具有异质性,其特征是参与胶原蛋白合成的基因突变,导致骨脆性增加、骨量量减少、骨材料性能受损以及骨基质矿化异常增高。隐性VI型OI是由SERPINF1基因突变引起的,导致色素上皮衍生因子(PEDF)功能丧失,PEDF是一种具有强大抗血管生成活性的胶原结合蛋白。受影响的患者会出现严重的OI表型,具有显著的组织学特征,即在其他OI类型中罕见的类骨质组织过多和矿化延迟时间延长。为了深入了解基质矿化情况,我们通过定量分析和高分辨率背散射电子成像对9名受影响儿童的活检样本进行了评估,并评估了骨矿化密度分布。通过同步加速器小角X射线散射对4名患者的子集测量了矿物颗粒的厚度、形状和排列。与对照组相比,发现骨基质中的典型钙含量增加,甚至超过了先前在患有胶原基因突变的OI患者中发现的值。然而,一个主要特征是这种高度矿化的骨基质与矿化含量异常低的骨缝共存。在年轻骨细胞的陷窝周围区域发现了非典型的胶原纤维组织,这表明矿化早期步骤受到干扰。这些观察结果与存在大小、形状和排列异常的异质性矿物颗粒群体一致,特别是在矿化含量较低的区域。高度矿化骨区域中的大多数颗粒比对照组和先前测量的OI患者中的颗粒排列更有序,但更小且堆积更密集。这些数据表明,PEDF的缺乏会损害成骨细胞向骨细胞的正常转变,从而影响矿化的早期步骤,下游的胶原组装使得VI型OI不同于具有I型胶原编码基因突变的“经典”OI,尽管骨基质存在典型的矿化过度。

相似文献

1
Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.人类VI型成骨不全症骨骼独特的微米和纳米级矿化模式。
Bone. 2015 Apr;73:233-41. doi: 10.1016/j.bone.2014.12.023. Epub 2014 Dec 29.
2
Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations.I 型成骨不全症患儿的矿物质颗粒大小并非独立于特定胶原突变而增加。
Bone. 2014 Mar;60:122-8. doi: 10.1016/j.bone.2013.11.023. Epub 2013 Dec 1.
3
Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta.在生长型 Ifitm5/BRIL p.S42 敲入小鼠中,骨骼材料特性的改变,一种新的非典型 6 型成骨不全症模型。
Bone. 2022 Sep;162:116451. doi: 10.1016/j.bone.2022.116451. Epub 2022 May 30.
4
Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.成骨不全症患儿生长过程中骨矿化异常增高与特定胶原蛋白突变无关的证据。
Calcif Tissue Int. 2008 Apr;82(4):263-70. doi: 10.1007/s00223-008-9113-x. Epub 2008 Mar 3.
5
Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.非致死性VIII型成骨不全症患者的骨基质矿化增强。
J Clin Endocrinol Metab. 2016 Sep;101(9):3516-25. doi: 10.1210/jc.2016-1334. Epub 2016 Jul 6.
6
Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice.恢复丝氨酸蛋白酶抑制剂F1(SERPINF1)的血清水平并不能纠正丝氨酸蛋白酶抑制剂F1基因敲除小鼠的骨骼表型。
Mol Genet Metab. 2016 Mar;117(3):378-82. doi: 10.1016/j.ymgme.2015.11.015. Epub 2015 Dec 2.
7
Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.VI型成骨不全症:一种伴有矿化缺陷的脆性骨病。
J Bone Miner Res. 2002 Jan;17(1):30-8. doi: 10.1359/jbmr.2002.17.1.30.
8
Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.成骨不全V型骨中的过度矿化和高骨细胞陷窝密度表明原发性骨形成旺盛。
J Bone Miner Res. 2017 Sep;32(9):1884-1892. doi: 10.1002/jbmr.3180. Epub 2017 Jun 26.
9
Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI.循环色素上皮衍生因子缺乏是成骨不全症 VI 型的标志物。
J Clin Endocrinol Metab. 2012 Aug;97(8):E1550-6. doi: 10.1210/jc.2012-1827. Epub 2012 Jun 5.
10
CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.CRTAP 缺乏症导致小鼠模型和 VII 型成骨不全症患儿的骨基质矿化异常升高。
Bone. 2010 Mar;46(3):820-6. doi: 10.1016/j.bone.2009.10.037. Epub 2009 Nov 4.

引用本文的文献

1
The Role of PEDF in the Eye, Bone, and Nervous and Immune Systems.色素上皮衍生因子在眼睛、骨骼、神经及免疫系统中的作用
Pharmaceutics. 2025 Aug 15;17(8):1064. doi: 10.3390/pharmaceutics17081064.
2
Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models.成骨不全斑马鱼模型中抗吸收和新型合成代谢药物联合治疗方法
JBMR Plus. 2025 Jul 2;9(9):ziaf112. doi: 10.1093/jbmrpl/ziaf112. eCollection 2025 Sep.
3
Understanding the structural biology of osteomalacia through multiscale 3D X-ray and electron tomographic imaging: a review of X-linked hypophosphatemia, the mouse model, and imaging methods.
通过多尺度三维X射线和电子断层成像理解骨软化症的结构生物学:对X连锁低磷血症、小鼠模型及成像方法的综述
JBMR Plus. 2024 Dec 30;9(2):ziae176. doi: 10.1093/jbmrpl/ziae176. eCollection 2025 Feb.
4
Improvement of bone properties in children with osteogenesis imperfecta after pamidronate: a bone biopsy study.帕米膦酸治疗后成骨不全患儿骨特性的改善:一项骨活检研究
JBMR Plus. 2024 Dec 11;9(2):ziae161. doi: 10.1093/jbmrpl/ziae161. eCollection 2025 Feb.
5
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.骨质量和矿化及成骨不全症治疗的影响。
Calcif Tissue Int. 2024 Dec;115(6):777-804. doi: 10.1007/s00223-024-01263-8. Epub 2024 Sep 4.
6
Update on the Genetics of Osteogenesis Imperfecta.成骨不全症遗传学的最新进展。
Calcif Tissue Int. 2024 Dec;115(6):891-914. doi: 10.1007/s00223-024-01266-5. Epub 2024 Aug 11.
7
Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta.特立帕肽序贯唑来膦酸治疗降低成骨不全症患者骨折风险的随机临床试验方案。
BMJ Open. 2023 Nov 22;13(11):e078164. doi: 10.1136/bmjopen-2023-078164.
8
Bone Material Properties in Bone Diseases Affecting Children.儿童骨骼疾病相关的骨材料特性。
Curr Osteoporos Rep. 2023 Dec;21(6):787-805. doi: 10.1007/s11914-023-00822-6. Epub 2023 Oct 28.
9
Investigating the role of ASCC1 in the causation of bone fragility.研究 ASCC1 在导致脆性骨折中的作用。
Front Endocrinol (Lausanne). 2023 Jun 30;14:1137573. doi: 10.3389/fendo.2023.1137573. eCollection 2023.
10
Bone mineral properties and 3D orientation of human lamellar bone around cement lines and the Haversian system.骨矿物质特性和人板层骨围绕骨水泥线和哈弗系统的 3D 取向。
IUCrJ. 2023 Mar 1;10(Pt 2):189-198. doi: 10.1107/S2052252523000866.